SCHEMBL4534787

SCHEMBL4534787

CC(C)(C)OC(=O)N1CC2CC1CN2C(=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 2/20 0.50
GPR119 Q8TDV5 1/20 0.49
HSD11B1 P28845 1/20 0.49
PDK1 Q15118 1/20 0.48
PDK2 Q15119 1/20 0.48
PDK3 Q15120 1/20 0.48
PDK4 Q16654 1/20 0.48
PARP1 P09874 2/20 0.47
HDAC1 Q13547 1/20 0.46
HTR2C P28335 1/20 0.46
ABCB1 P08183 1/20 0.46
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22001922 0.87 AGTR2 (0.51) AGTR2GPR119PDK1PDK2PDK3
SCHEMBL22001921 0.87 AGTR2 (0.51) AGTR2GPR119PDK1PDK2PDK3
SCHEMBL20587805 0.87 AGTR2 (0.51) AGTR2GPR119PDK1PDK2PDK3
SCHEMBL18591953 0.86 SMN1; SMN2 (0.51) AGTR2GPR119PDK1PDK2PDK3
SCHEMBL17794008 0.86 PARP1 (0.47) AGTR2GPR119PDK1PDK2PDK3
SCHEMBL5905807 0.85 PREP (0.50) AGTR2GPR119HSD11B1PARP1ABCB1
SCHEMBL13323340 0.85 PARP1 (0.54) AGTR2PDK1PDK2PDK3PDK4
SCHEMBL9587344 0.84 HDAC1 (0.50) AGTR2PDK1PDK2PDK3PDK4
SCHEMBL9865373 0.84 HDAC1 (0.50) AGTR2PDK1PDK2PDK3PDK4
SCHEMBL27225295 0.84 KMT2A (0.48) AGTR2GPR119HSD11B1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105264-A1 Substituted Nicotinamide Compounds MERCK SHARP & DOHME CORP. 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105264-A1 Substituted Nicotinamide Compounds SIRT1, NQO1, TXNRD2 AGTR2 2149/4885GPR119 1197/4885HSD11B1 2726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.